Logo image of FEAM

5E ADVANCED MATERIALS INC (FEAM) Stock Fundamental Analysis

NASDAQ:FEAM - Nasdaq - US33830Q2084 - Common Stock - Currency: USD

5.2  -0.02 (-0.38%)

Fundamental Rating

0

FEAM gets a fundamental rating of 0 out of 10. The analysis compared the fundamentals against 153 industry peers in the Metals & Mining industry. FEAM may be in some trouble as it scores bad on both profitability and health. FEAM does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FEAM had negative earnings in the past year.
FEAM had a negative operating cash flow in the past year.
In the past 5 years FEAM always reported negative net income.
In the past 5 years FEAM always reported negative operating cash flow.
FEAM Yearly Net Income VS EBIT VS OCF VS FCFFEAM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -20M -40M -60M

1.2 Ratios

The Return On Assets of FEAM (-92.41%) is worse than 92.16% of its industry peers.
Industry RankSector Rank
ROA -92.41%
ROE N/A
ROIC N/A
ROA(3y)-64.57%
ROA(5y)-47.91%
ROE(3y)-247.59%
ROE(5y)-158.22%
ROIC(3y)N/A
ROIC(5y)N/A
FEAM Yearly ROA, ROE, ROICFEAM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 -100 -200 -300 -400 -500

1.3 Margins

FEAM does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FEAM Yearly Profit, Operating, Gross MarginsFEAM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024

More info and screens

0

2. Health

2.1 Basic Checks

Compared to 1 year ago, FEAM has less shares outstanding
Compared to 1 year ago, FEAM has a worse debt to assets ratio.
FEAM Yearly Shares OutstandingFEAM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M
FEAM Yearly Total Debt VS Total AssetsFEAM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

FEAM has an Altman-Z score of -5.60. This is a bad value and indicates that FEAM is not financially healthy and even has some risk of bankruptcy.
FEAM has a Altman-Z score of -5.60. This is amonst the worse of the industry: FEAM underperforms 90.20% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.6
ROIC/WACCN/A
WACCN/A
FEAM Yearly LT Debt VS Equity VS FCFFEAM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M -60M

2.3 Liquidity

FEAM has a Current Ratio of 0.15. This is a bad value and indicates that FEAM is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.15, FEAM is doing worse than 92.81% of the companies in the same industry.
FEAM has a Quick Ratio of 0.15. This is a bad value and indicates that FEAM is not financially healthy enough and could expect problems in meeting its short term obligations.
FEAM has a worse Quick ratio (0.15) than 92.81% of its industry peers.
Industry RankSector Rank
Current Ratio 0.15
Quick Ratio 0.15
FEAM Yearly Current Assets VS Current LiabilitesFEAM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for FEAM have decreased strongly by -1001.12% in the last year.
EPS 1Y (TTM)-1001.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

FEAM is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -145.95% yearly.
Based on estimates for the next years, FEAM will show a very strong growth in Revenue. The Revenue will grow by 85.38% on average per year.
EPS Next Y-849.72%
EPS Next 2Y-216.54%
EPS Next 3Y-145.95%
EPS Next 5YN/A
Revenue Next Year-100%
Revenue Next 2Y-72.78%
Revenue Next 3Y85.38%
Revenue Next 5YN/A

3.3 Evolution

FEAM Yearly Revenue VS EstimatesFEAM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2026 2027 2M 4M 6M 8M
FEAM Yearly EPS VS EstimatesFEAM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 -5 -10 -15 -20 -25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for FEAM. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for FEAM. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FEAM Price Earnings VS Forward Price EarningsFEAM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FEAM Per share dataFEAM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -2 -4 -6 -8

4.3 Compensation for Growth

A cheap valuation may be justified as FEAM's earnings are expected to decrease with -145.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-216.54%
EPS Next 3Y-145.95%

More info and screens

0

5. Dividend

5.1 Amount

FEAM does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

5E ADVANCED MATERIALS INC

NASDAQ:FEAM (4/28/2025, 5:15:24 PM)

5.2

-0.02 (-0.38%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)N/A N/A
Inst Owners19.24%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner Change5.48%
Market Cap93.60M
Analysts80
Price Target29.58 (468.85%)
Short Float %3.2%
Short Ratio1.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.49%
Min EPS beat(2)-2.94%
Max EPS beat(2)1.96%
EPS beat(4)2
Avg EPS beat(4)-33.11%
Min EPS beat(4)-194.11%
Max EPS beat(4)62.65%
EPS beat(8)4
Avg EPS beat(8)-20.68%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)1684.62%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-773.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-1368.27%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)-100%
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-9.8
EYN/A
EPS(NY)-8.22
Fwd EYN/A
FCF(TTM)-1.57
FCFYN/A
OCF(TTM)-1.32
OCFYN/A
SpS0
BVpS-0.47
TBVpS-0.47
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -92.41%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-64.57%
ROA(5y)-47.91%
ROE(3y)-247.59%
ROE(5y)-158.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 30.08%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.15
Quick Ratio 0.15
Altman-Z -5.6
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5445.43%
Cap/Depr(5y)14567.3%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1001.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1912.5%
EPS Next Y-849.72%
EPS Next 2Y-216.54%
EPS Next 3Y-145.95%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year-100%
Revenue Next 2Y-72.78%
Revenue Next 3Y85.38%
Revenue Next 5YN/A
EBIT growth 1Y-32.3%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.36%
EBIT Next 3Y-0.19%
EBIT Next 5YN/A
FCF growth 1Y50%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y25.65%
OCF growth 3YN/A
OCF growth 5YN/A